Evidence map›Paper›PMID 41200279›Full record

ReviewMedComm2025

Artificial Intelligence for the Diagnosis and Management of Cancers: Potentials and Challenges.

Man Wang, Wenguang Chang, Yuan Zhang

Abstract readReview
In one paragraph

Review in MedComm, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Man WangInstitute For Translational Medicine The Affiliated Hospital of Qingdao University College of Medicine Qingdao University Qingdao China.ORCID https://orcid.org/0000-0001-7190-4582
Wenguang ChangInstitute For Translational Medicine The Affiliated Hospital of Qingdao University College of Medicine Qingdao University Qingdao China.
Yuan ZhangInstitute For Translational Medicine The Affiliated Hospital of Qingdao University College of Medicine Qingdao University Qingdao China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cancer continues to be one of the primary causes of death worldwide. Although there has been substantial progress in clinical cancer care, the outcomes for cancer patients still remain poor. The rapid advancements of artificial intelligence (AI) will revolutionize cancer management by addressing current obstacles in oncology research and practice, ultimately enhancing healthcare accuracy and patient outcomes. Increasing evidence demonstrates that AI-based models can improve the accuracy and efficiency of cancer diagnosis and treatment by leveraging multilayer data. Cancer patients could greatly benefit from AI's promising prospects, yet few AI models have been authorized for clinical use. A comprehensive understanding of AI's basic principles, applications, and potential impacts is essential to foster its clinical translation. In this review, we provide an overview of fundamental AI techniques, encompassing machine learning and deep learning. Moreover, we summarize recent studies on AI's transformative role in cancer diagnosis, classification, and personalized treatment planning. Furthermore, we discuss the current challenges that hinder the widespread use of AI, propose potential solutions, and outline future directions. Overall, through systematic analysis of existing preclinical and clinical evidence, this review highlights the substantial potential of AI technology and provides valuable guidance for future research in AI-driven oncology.

Indexed as

artificial intelligencecancercancer diagnosispersonalized cancer therapyprognosis prediction

Identifiers

PMID41200279
PMCPMC12587170

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.